Year of Award:
Molecular & Cellular Analysis Technologies
MURPHY, JOHN R.
Other PI or Project Leader:
BOSTON MEDICAL CENTER
A detailed understanding of the genetic basis of neoplastic diseases has emerged during the past two decades which has encouraged efforts to develop genetically targeted reagents both as experimental tools and as novel anti-cancer drugs. Peptide nucleic a